Aug 15 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- Eli Lilly raises UK price of obesity drug by up to 170% after Trump 'freeloading' gripe
- Unite agrees to buy rival student landlord Empiric in 723 million pounds deal
- EG Group to sell Australian business for 530 million pounds in debt-reduction drive
Overview
- Eli Lilly LLY.N will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line with other European markets.
- Unite Group UTG.L has agreed to buy rival UK student landlord Empiric Student Property ESP.L for about 723 million pounds ($978.58 million).
- Australia's Ampol ALD.AX said on Thursday it would buy British fuel station operator EG Group's local unit, EG Australia, for roughly 530 million pounds ($717.4 million).
($1 = 0.7388 pounds)
(Compiled by Bengaluru newsroom)
((globalnewsmonitoring@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.